Search Results for: behind the study
![Dr. Dechao Feng](https://www.impactjournals.com/wp-content/uploads/2023/10/Screen-Shot-2023-10-23-at-5.11.56-PM-300x169.png)
Behind the Study: Senescence-Related lncRNA Prognostic Index in Prostate Cancer
Dr. Dechao Feng from the Department of Urology, Institute of Urology, West China Hospital, Sichuan University, discusses a research paper he co-authored that was published by Aging (Aging-US) in Volume 15, Issue 18, entitled, “Identification of senescence-related lncRNA prognostic index correlating with prognosis and radiosensitivity in prostate cancer patients.”
![Dr. Frank Pun](https://www.impactjournals.com/wp-content/uploads/2023/10/Screen-Shot-2023-10-25-at-6.43.39-AM-300x153.png)
Behind the Study: Biomedical Transformer Language Model for Age-Related Disease Discovery
Dr. Frank Pun, Diana Zagirova, Dr. Anatoly Urban, and Geoffrey Ho Duen Leung from Insilico Medicine Hong Kong Ltd., discuss a research paper they co-authored that was published by Aging (Aging-US) in Volume 15, Issue 18, entitled, “Biomedical generative pre-trained based transformer language model for age-related disease target discovery.”
![Dr. Wenbo Yu, Stanley](https://www.impactjournals.com/wp-content/uploads/2023/10/Screen-Shot-2023-10-20-at-8.30.57-AM-300x168.png)
Behind the Study: Poisson Distribution-Based Model of Cancer Rates & Cancer Risk-Dependent Theory of Aging
Dr. Wenbo Yu, Stanley from the Centre for Cancer Biology, SA Pathology and University of South Australia details a research perspective he co-authored that was published by Aging (Aging-US) in Volume 15, Issue 17, entitled, “A Poisson distribution-based general model of cancer rates and a cancer risk-dependent theory of aging.”
![Dr. Lennard YW Lee](https://www.impactjournals.com/wp-content/uploads/2023/10/Screen-Shot-2023-10-12-at-4.16.23-PM-300x169.png)
Behind the Study: Global Pandemic Exit Strategy: Equity and Immunity
Dr. Lennard YW Lee, Yuxin Ying and Jola Bytyci from the University of Oxford, UK, elaborate on a recent editorial they co-authored that was published by Oncoscience in Volume 10, entitled, “Exiting the pandemic together: achieving global immunity and equity.”
![Dr. Omkar Desai](https://www.impactjournals.com/wp-content/uploads/2023/10/Screen-Shot-2023-10-12-at-10.47.33-AM-300x169.png)
Behind the Study: HER3: A Vital Target in Cancer Treatment
Dr. Omkar Desai describes a research perspective he co-authored with Dr. Rui Wang that was published by Oncotarget in Volume 14, entitled, “HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma.”